Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

NCT02707458 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Dementia of the Alzheimer Type
Age-related Cognitive Decline
Mild Cognitive Impairment Due to Alzheimer Disease

Interventions

DRUG: Probucol

Sponsor

Douglas Mental Health University Institute

Collaborators

[object Object]
[object Object]